DOI: https://doi.org/10.30841/2307-5112.2.2019.174626

Ожирение и артериальная гипертензия: современные взгляды на патогенез, диагностику и лечение

О. Ю. Горопко

Аннотация


В статье рассмотрены вопросы патогенеза ожирения и артериальной гипертензии, особенностей жирового обмена, антропометрического и морфометрического обследования методом биоэлектрического импеданс-анализа пациентов с артериальной гипертензией и ожирением.

Ключевые слова


ожирение; артериальная гипертензия; биоэлектрический импеданс-анализ; адипокины; лептин; патогенез; лечение

Полный текст:

PDF (Українська)

Литература


https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight

Danaei G., Singh G.M., Paciorek C.J., Lin J.K., Cowan M.J., Finucane M.M., ... & Rao M. (2013). The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation, 127(14), 1493-1502.

Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.

Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation. 2000;101:329-35. [PMID: 10645931]

Calhoun DA, Bakir SE, Oparil S. Etiology and pathogenesis of essential hypertension. In: Crawford MH, DiMarco JP, eds. Cardiology. London: Mosby International; 2000:3.1-3.10

Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-56. [PMID: 11239411]

Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913-23. [PMID: 11907292]

Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.

Високий нормальний рівень артеріального тиску чи «передгіпертензія»? Дослідження TROPHY / О.Й. Жарінов // Медицина світу (Львів). – 2006. – Т. 20, № 7. – С. 49–54.

Whelton P.K., Carey R.M., Aronow W.S., Casey D.E., Collins K.J., Himmelfarb C.D., MacLaughlin E.J. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 71(19), e127-e248.

Bryan Williams, Giuseppe Mancia, Wilko Spiering, Enrico Agabiti Rosei, Michel Azizi, Michel Burnier, Denis L Clement, Antonio Coca, Giovanni de Simone, Anna Dominiczak, Thomas Kahan, Felix Mahfoud, Josep Redon, Luis Ruilope, Alberto Zanchetti, Mary Kerins, Sverre E Kjeldsen, Reinhold Kreutz, Stephane Laurent, Gregory Y H Lip, Richard Mc- Manus, Krzysztof Narkiewicz, Frank Ruschitzka, Roland E Schmieder, Evgeny Shlyakhto, Costas Tsioufis, Victor Aboyans, Ileana Desormais, 2018 ESC/ESH Guidelines for the management of arterial hypertension, European Heart Journal, Volume 39, Issue 33, 01 September 2018, Pages 3021–3104.

Kearney PM, Whelton M, Reynolds K, Whelton PK, He J (January 2004). Worldwide prevalence of hypertension: a systematic review. J. Hypertens. 22 (1): 11–9. PMID 15106785

Carretero OA, Oparil S (January 2000). Essential hypertension. Part I: Definition and etiology. Circulation 101 (3): 329–35. PMID 10645931. doi:10.1161/01.CIR.101.3.329.

He FJ; MacGregor, GA (2009 Jun). A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. Journal of human hypertension 23 (6): 363–84. PMID 19110538.

Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003 Nov 4;139(9):761-76.

Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113-26.

Vaidya A, Forman JP (November 2010). Vitamin D and hypertension: current evidence and future directions. Hypertension 56 (5): 774–9. PMID 20937970. doi:10.1161/HYPERTENSIONAHA.109.140160.

Guyton AC. Blood pressure control special role of the kidneys and body fluids. Science. 1991;252:1813-6. [PMID: 2063193]

Струков А.И., Серов В.В. Библиография: Патологическая анатомия: учебник / А.И. Струков, В.В. Серов. – 5-е изд., стер. – М.: Литтерра, 2010. – 880 с.: ил., стр. 360–372.

Ashley FW Jr, Kannel WB. Relation of weight change to changes in atherogenic traits: Framingham Study. J Chronic Dis. 1974;27: 103–114.

Haslam DW, James WP (2005). Obesity. Lancet 366 (9492): 1197–209. PMID 16198769. doi:10.1016/S0140-6736(05)67483-1

Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432.

Díez J. Insulin-like growth factor I in essential hypertension. Kidney Int. 1999;55:744 –759.

Wauman J, Tavernier J. Leptin receptor signaling: pathways to leptin resistance. Front Biosci (Landmark Ed) 2011;16:2771–2793.

Jung CH, Kim MS. Molecular mechanisms of central leptin resistance in obesity. Arch Pharm Res. 2013;36:201–207.

Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Obesity-induced hypertension: new concepts from the emerging biology of obesity [state-of-the-art lecture]. Hypertension. 1999;33:537–541.

Antonopoulos AS, Margaritis M, Coutinho P, Digby J, Patel R, Psarros C, Ntusi N, Karamitsos TD, Lee R, De Silva R, Petrou M, Sayeed R, Demosthenous M, Bakogiannis C, Wordsworth PB, Tousoulis D, Neubauer S, Channon KM, Antoniades C. Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 2014;34:2151–2159.

Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R, Sata M. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol 2010;30:1576–1582.

Aghamohammadzadeh R, Greenstein AS, Yadav R, Jeziorska M, Hama S, Soltani F, Pemberton PW, Ammori B, Malik RA, Soran H, Heagerty AM. Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity. J Am Coll Cardiol 2013;62:128–135.

Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006;290:E961–E967.

Antonopoulos, Alexios S., and Dimitris Tousoulis. The molecular mechanisms of obesity paradox. Cardiovascular research 113.9 (2017): 1074-1086.

Hermann L. Ueber eine Wirking galvanischer Strome auf Muskeln und Nerven. Pflugers Arch gesamte Physiol 1871;5:223–75.

Kyle, Ursula G., et al. Bioelectrical impedance analysis-part I: review of principles and methods. Clinical nutrition 23.5 (2004): 1226-1243.

Степанов Ю.М., Бойко Т.Й., Сорочан О.В., Стойкевич М.В., and Шкаредна А.С. Біоімпедансметрія в оцінці нутритивного статусу хворих на хронічні запальні захворювання кишечника / Гастроентерологiя. – 2015. – Vol. 56, № 2. – Р. 59–66.

Гайворонский И.В., Ничипорук Г.И., Гайворонский И.Н., Ничипорук Н.Г. Биоимпедансометрия как метод оценки компонентного состава тела человека (обзор литературы) // Вестник СПбГУ. – Медицина, 2017. – Т. 12. Вып. 4. – С. 365–384.

Биоимпедансный анализ состава тела человека / Д.В. Николаев, А.В. Смирнов, И.Г. Бобринская, С.Г. Руднев. – М.: Наука, 2009. – 392 с.

Мартиросов Э.Г., Николаев Д.В., Руднев С.Г. Технологии и методы определения состава тела человека. – М.: Наука, 2006. – 256 с.

Khalil S., Mohktar M., Idrahim F. The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of disease // Sensors (Basel). – 2014. – Vol. 14, N 6. – P. 10895–10928.

Николаев Д.В. Биоимпедансный анализ: основы метода. Протокол обследования и интерпретация результатов // Спортивная медицина: наука и практика. 2012. – Вып. 2. – С. 29–36.

Wang J., Thornton J.C., Kolesnik S., Pierson R.N. // Ann. N.Y. Acad. Sci. Anthropometry in body composition: Anoverview. – 2000. – Vol. 904. – P. 31.

Zamrazilova H., Hlavaty P., Dusatkova L. [et al.] A new simple method for estimating trunk and visceral fat by bioelectrical impedance: comparison with magnetic resonance imaging and dual Xray absorptiometry in Czech adolescents // Cas. Lek. Cesk. – 2010. – Vol. 149, № 9. – P. 417–422.

Rodriguez P.N., Bermudez E.F., Rodriguez G.S. [et al.] Body composition by simple anthropometry, bioimpedance and DXA in preschool children: interrelationships among methods // Arch. Argent. Pediatr. – 2008. – Vol. 106, № 2. – P. 102–109.

Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.

Hassink S.G., Sheslow D.V., de Lancey E. et al. Serum leptin in children with obesity: relationship to gender and development // Pediatrics. 1996, 98, 201-203.

Lord G.M., Matarese G., Howard J.K. et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression // Nature. 1998, 394, 897-901.

Maffei M., Hallas J., Ravussin E. et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects // Nat. Med. 1995, 1, 1155-116.

Banerjee R.R., Lazar M.A. Dimerization of resistin and resistin-like molecules is determined by a single cysteine // J. Biol. Chem. 2001, 276, 25970-25973.

McTernan C.L., McTernan P.G., Harte A.L. et al. Resistin, central obesity, and type 2 diabetes // Lancet. 2002, 36, 46-47.

Lee J.H., Chan J.L., Yiannakouris N. et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulinresistant, and diabetic subjects.

Janke J., Engeli S., Gorzelniak K. et al. Resistin gene expression in human adipocytes is not related to insulin resistance // Obes. Res. 2002, 10, 1-5.

Burnett M.S., Devaney J.M., Adenika R.J. CrossSectional Associations of Resistin, Coronary Heart Disease, and Insulin Resistance // J. Clin. Endocrinol. Metab. 2006, 91, № 1, 64–68.

Antonopoulos, Alexios S., and Dimitris Tousoulis. The molecular mechanisms of obesity paradox. Cardiovascular research 113.9 (2017): 1074–1086.

Lihn A.S., Pedersen S.B., Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity // Obes. Rev. 2005, 6, 13–21.

Bacha F., Saad R., Gungor N., Arslanian S.A. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function // Diabetes Care. 2004, 27, 547–552.




Copyright (c) 2019 Семейная медицина

Creative Commons License
Эта работа лицензирована Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-8708 (Online), ISSN 2307-5112 (Print)

Flag Counter